Revvity reported $227.55M in EBITDA for its fiscal quarter ending in September of 2026.





Ebitda Change Date
Agilent USD 577M 77M Jun/2026
Align Technology USD 232.86M 3.72M Jun/2026
Bio Techne USD 115.94M 763K Jun/2026
Bio-Rad Laboratories USD 119.9M 475.4M Sep/2026
Bruker USD 143.2M 33.2M Jun/2026
Celltrion KRW 25.72B 6.08B Jun/2026
Charles River Laboratories USD 298.04M 25.1M Sep/2026
Cspc Pharmaceutical CNY 2.19B 21.88M Dec/2024
Danaher USD 2.1B 257M Sep/2026
Dentsply International USD 146M 44M Sep/2026
Deva Holding AS TRY 882.9M 201.7M Sep/2023
Dianthus Therapeutics USD -61.38M 14.92M Jun/2026
Divis Laboratories Ltd INR 15.66B 3.04B Sep/2026
Edwards Lifesciences USD 562.2M 6.6M Jun/2026
Illumina USD 330M 80M Jun/2026
Intuitive Surgical USD 1.2B 147.7M Jun/2026
IQVIA Holdings USD 1.03B 38M Sep/2026
Kangmei Pharma CNY -12.72M 30.02M Mar/2026
Knight Therapeutics CAD 24.45M 3.46M Dec/2025
Laboratorios Farma EUR 34.94M 102.95M Jun/2025
Laboratory Of America USD 674.3M 93.4M Sep/2026
Malin Corporation EUR -1.1M 200K Dec/2024
Medical Developments International AUD 1.78M 3.78M Dec/2024
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Mettler Toledo International USD 366.1M 43.45M Sep/2026
Myriad Genetics USD 14.3M 4M Dec/2025
Neuren Pharmaceuticals AUD 11.14M 165.56M Dec/2025
OraSure Technologies USD -17.7M 4.06M Dec/2025
Organigram Holdings CAD 15.45M 20.21M Jun/2026
Pacific Biosciences Of California USD -35.4M 5.78M Sep/2025
Pharma Mar EUR 9.63M 8.93M Sep/2026
Qiagen NV USD 219.78M 12.13M Sep/2026
Quest Diagnostics USD 627M 21M Sep/2026
Quidel USD 148M 18.7M Sep/2026
Repligen USD 43.84M 70K Sep/2026
Revvity USD 227.55M 629K Sep/2026
Sartorius EUR 279.9M 600K Sep/2026
Sino Biopharmaceutical CNY 2.59B 1.57B Dec/2024
Thermo Fisher Scientific USD 3.79B 244M Sep/2026
Tilray USD 8.36M 1.82M Sep/2025
Waters USD 554M 158M Sep/2026
Zealand Pharma A/S -379M 348.47M Mar/2026
Zhangzhou Pientzehuang Pharmaceutical CNY 419.24M 463.46M Jun/2026